ALSPW Spineway SAS

SPINEWAY: Half-year financial statements 2024

SPINEWAY: Half-year financial statements 2024

SPINEWAY

Half-year financial statements 2024

Attachment



EN
23/09/2024

Underlying

ALSPWSpineway SAS

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Spineway SAS

 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

Spineway generates great interest at the EUROSPINE 2024 Congress in Vi...

Spineway generates great interest at the EUROSPINE 2024 Congress in Vienna Press release       Ecully, October 22, 2024 – 6 p.m. Spineway generates great interest at the EUROSPINE 2024 Congress in Vienna The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, took part in the , Europe’s leading spine conference, held from October 2 to 4, in Vienna, Austria. During the event, which brought together more than 3,500 spine surgeons and professionals from all over the world, Spineway enjoyed a prime location in the heart of the Messe Wien congr...

October 22, 2024 1 EN
 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

Spineway : Continued organic growth - Nine-month 2024 revenue of €9.1 ...

Spineway : Continued organic growth - Nine-month 2024 revenue of €9.1 million (+21%) Press release         Ecully, October 15, 2024 – 6 p.m. SPINEWAY Continued organic growthNine-month 2024 revenue of €9.1 million (+21%) In thousands of euros20242023Change %Q1 revenue3,0702,39828%Q2 revenue3,4653,03314%Q3 revenue2,5752,07724%9M revenue9,1107,51021% Unaudited consolidated data The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, recorded an excellent third quarter in 2024, with revenue of €2.6 million, representing purely organic growth (...

October 15, 2024 1 EN
 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

SPINEWAY : Poursuite de la croissance organique - Chiffre d’affaires à...

SPINEWAY : Poursuite de la croissance organique - Chiffre d’affaires à 9 mois 2024 de 9,1 M€ (+ 21%) Communiqué de presse          Ecully, le 15 octobre 2024 –18h SPINEWAY Poursuite de la croissance organiqueChiffre d’affaires à 9 mois 2024 de 9,1 M€ (+ 21%) En milliers d’euros20242023Variation en %CA 1er trimestre3 0702 398+ 28%CA 2ème trimestre3 4653 033+ 14%CA 3ème trimestre2 5752 077+ 24%CA 9 mois9 1107 510+ 21% Données consolidées non auditées Spineway, spécialiste des implants innovants pour le traitement des pathologies sévères de la colonne vertébrale (rachis), a réalisé un t...

October 15, 2024 1 EN
 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

SPINEWAY: Half-year financial statements 2024

SPINEWAY: Half-year financial statements 2024 SPINEWAY Half-year financial statements 2024 Attachment

September 23, 2024 1 EN
 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

SPINEWAY : Rapport semestriel 2024

SPINEWAY : Rapport semestriel 2024 SPINEWAY Comptes semestriels 2024 et rapport d'activité  Pièce jointe

September 23, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch